Chitosan: A versatile bio-platform for breast cancer theranostics.
Madamsetty VS, Tavakol S, Moghassemi S, Dadashzadeh A, Schneible JD, Fatemi I, Shirvani A, Zarrabi A, Azedi F, Dehshahri A, Aghaei Afshar A, Aghaabbasi K, Pardakhty A, Mohammadinejad R, Kesharwani P.
Madamsetty VS, et al.
J Control Release. 2022 Jan;341:733-752. doi: 10.1016/j.jconrel.2021.12.012. Epub 2021 Dec 11.
J Control Release. 2022.
PMID: 34906606
Review.
Abundant studies were directed to assess the chitosan derivative-based nanoformulation's abilities in delivering varieties of drugs. However, the role of chitosan in diagnostics and theranostics not be obligated. ...
Abundant studies were directed to assess the chitosan derivative-based nanoformulation's abilities in delivering varieties of drugs. …